【英文タイトル】OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecasts to 2017



1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 11
1.2 List of Figures 13
2 Introduction 14
2.1 Catalyst 14
2.2 Related Reports 14
3 Disease Overview 15
3.1 Etiology and Pathophysiology 15
3.2 Etiology 17
3.3 Pathophysiology 17
3.4 Clinical Prognosis 20
3.5 Quality of Life 20
3.6 Symptoms and Diagnosis 21
4 Epidemiology 22
4.1 Risk Factors and Comorbidities 22
4.1.1 Family history is a strong predictor for the risk of endometriosis 22
4.1.2 Late age at menarche protects women from developing endometriosis. 23
4.1.3 Higher parity decreases the risk for endometriosis 24
4.2 Global Trends 26
4.2.1 US 27
4.2.2 5EU 27
4.2.3 Forecast Methodology 28
4.2.4 Sources Used 29
4.2.5 Sources Not Used 32
4.2.6 Forecast Assumptions and Methods 32
4.3 Epidemiological Forecast for Endometriosis (2012-2022) 35
4.3.1 Diagnosed Prevalent Cases of Endometriosis 35
4.3.2 Age-Specific Prevalent Cases of Endometriosis 36
4.3.3 Age-Standardized Diagnosed Prevalence of Endometriosis 38
4.3.4 Diagnosed Prevalent Cases of Endometriosis by Stage 39
4.4 Discussion 41
4.4.1 Epidemiological Forecast Insight 41
4.4.2 Limitations of the Analysis 42
4.4.3 Strengths of the Analysis 43
5 Current Treatment Options 45
5.1 Overview 45
5.2 Product Profiles – Major Brands 48
5.2.1 Zoladex (goserelin acetate) 48
5.2.2 Lupron (leuprolide acetate depot) 51
5.2.3 Synarel (nafarelin nasal spray) 53
5.2.4 Visanne (dienogest) 56
5.2.5 Depo-SubQ Provera 104 (medroxyprogesterone injection) 59
5.2.6 Danazol (Danocrine) 61
5.2.7 Off-Label Treatment: Combined Oral Contraceptives, Progestins, and NSAIDs 63
6 Unmet Needs Assessment and Opportunity Analysis 67
6.1 Overview 67
6.2 Unmet Needs Analysis 68
6.2.1 Unmet Need: Non-Invasive Diagnostics 68
6.2.2 Unmet Need: Non-Hormonal Therapies 69
6.2.3 Unmet Need: Better Pain Management 69
6.2.4 Unmet Need: Better Understanding of the Disease Pathology to Prevent Recurrence 70
6.2.5 Unmet Need: Identification of Biomarkers 71
6.2.6 Unmet Need: Transparency in Clinical Trials 71
6.3 Opportunity Analysis 72
6.3.1 Opportunity: Biomarkers Identification 72
6.3.2 Opportunity: Treatment Options for Adolescents 73
6.3.3 Opportunity: Drugs Targeting Pain Pathways 73
6.3.4 Opportunity: Novel Targets 74
6.3.5 Opportunity: Efficacious Treatments Suitable for Long-Term Use 74
6.4 Research and Development Strategies 75
6.4.1 Overview 75
6.4.2 The Race for the Development of GnRH Antagonists 76
6.4.3 Alliances and In-Licensing Strategies 76
6.4.4 Maximizing Return-on-Investment by Targeting Secondary indications 77
6.5 Clinical Trial Design 78
6.5.1 Overview 78
6.5.2 Defining Efficacy in Endometriosis Clinical Trials 78
6.5.3 Future Trends in Endometriosis Clinical Trial Design 83
7 Pipeline Assessment 84
7.1 Overview 84
7.2 Promising Drugs in Development 85
7.2.1 Elagolix (ABT-602) 86
7.2.2 Relugolix (TAK-385) 90
7.2.3 ASP-1707 92
7.3 Innovative Early-Stage Approaches 94
7.3.1 Overview 94
7.3.2 Anti-Inflammatory Approaches 96
7.3.3 Cellular Adhesion 97
7.3.4 Angiogenesis Endometriotic Implants 97
7.3.5 Selective Progesterone Receptor Modulators 98
7.3.6 Aromatase Inhibitors 99
8 Pipeline Valuation Analysis 100
8.1 Overview 100
8.2 Clinical Benchmarking of Key Pipeline Drugs 100
8.3 Commercial Benchmarking of Key Pipeline Drugs 104
8.4 Competitive Assessment 105
8.5 Top-Line, Five-Year Forecasts 106
8.5.1 Overview 106
8.5.2 US 109
8.5.3 5EU 110
9 Appendix 112
9.1 Bibliography 112
9.2 Abbreviations 123
9.3 Methodology 126
9.4 Forecasting Methodology 126
9.4.1 Diagnosed Endometriosis Patients 127
9.4.2 Percent Drug Treated Patients 128
9.4.3 Drugs Included in Each Therapeutic Class 129
9.4.4 Launch and Patent Expiry Dates 129
9.4.5 General Pricing Assumptions 130
9.4.6 Individual Drug Assumptions 130
9.4.7 Generic Erosion 133
9.4.8 Pricing of Pipeline Agents 133
9.5 Physicians and Specialists Included in This Study 134
9.6 About the Authors 135
9.6.1 Author 135
9.6.2 Epidemiologist 135
9.6.3 Global Director of Epidemiology and Health Policy 136
9.6.4 Global Head of Healthcare 136
9.7 About GlobalData 137
9.8 Disclaimer 137


■ タイトル:子宮内膜症:市場分析及び予測(~2017)
■ 英文:OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecasts to 2017
■ 発行日:2013年12月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403163446
■ 調査対象地域:グローバル
  • 高級ハンドバッグの世界市場2019-2023
    About this market Vendors are constantly reforming and introducing new designs and patterns owing to growing competition and customer demand arising from rapid changes in the fashion industry. Customers seek luxury handbags for formal (especially leather handbags) and casual purposes (such as metal and precious stone studded handbags). To meet such evolving customer needs: vendors regularly expand …
  • ITインフラ・アウトソーシングの世界市場2015-2019
    About Infrastructure Outsourcing Infrastructure outsourcing refers to the outsourcing of data centers, desktop services, help desks, networks, and other related services. This enables the transfer of managerial responsibilities that include offering an optimized, secure, and scalable IT infrastructure to an external provider. The demand for service integration and automation of infrastructure serv …
  • ブルー・バイオテクノロジーの世界市場2019-2023
    About this market The driving factors of the global blue biotechnology market is the increasing commercial use in the different fields. This is one of the driving factor that will trigger the growth of global blue biotechnology market during the forecast period. Applications of blue technology range over several fields like health care, plant biology, water treatment, research and production of su …
  • 世界の中枢神経系(CNS)バイオマーカー市場
    A biomarker is biological feature that can be used to measure the presence or progress of disease or the effects of treatment. For example, prostate specific antigen (PSA) is a biomarker for cancer of prostate. Biomarkers enable the researchers to quickly see large number of biological analytics. The global market value of the Global CNS Biomarker market is expected to be a billion dollar opportun …
  • 世界のNFV(ネットワーク機能仮想化)市場(2014-2018)
    TechNavio's analysts forecast the Global Network Function Virtualization market to grow at a CAGR of 51.57 percent over the period 2013-2018. One of the key factors contributing to this market growth is the astronomical growth in bandwidth-intensive applications. The Global Network Function Virtualization market has also been witnessing the decline in revenue per bit. However, the delay in the ado …
  • 細菌性心内膜炎:治療薬のグローバル治験動向(2014年下半期)
    Bacterial Endocarditis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Bacterial Endocarditis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Endocarditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Endocarditis. It includes an overview of the trial numbers and …
  • OSDF (経口固形製剤) 用ポリマー系溶解性強化賦形剤の世界市場
    About polymer-based solubility enhancement excipients for OSDF Excipients are inactive components of a drug that are used in conjunction with API. Although they are often referred to being inert, excipients play important functional roles in drug delivery. Some of the key functions include binding, flavoring, coloring, lubricating, and enhancing solubility of the drug. Solubility enhancing excipie …
  • 世界のスマートフォン用オーディオ・コーデック市場
    About Smartphone Audio Codecs A smartphone audio codec contains microphone and line inputs, signal routing and mixing channels, amplifier blocks, and multiple analog-to-digital converter (ADC) and digital-to-analog converter (DAC) channels. It also consists of a variety of output drivers, including line outputs, and headphone and loudspeaker drivers as well as a small digital processing block cons …
  • PETスキャナの世界市場:PET、ハイブリッドPET/CT、PET/MRI
    About PET Scanners Cancer is one of the leading causes of death worldwide. According to WHO, in 2012, it accounted for 8.2 million deaths worldwide, of which lung cancer was the cause of 1.59 million deaths. According to the American Cancer Society, as of 2014, there were 430,090 lung cancer survivors in the US. To treat cancer patients, it is necessary to determine the stage, its location, and wh …
  • スティック型包装材の世界市場:ポリエステル、紙、BOPP、アルミニウム、金属化ポリエステル、ポリエチレン、ポリプロピレン
    Stick packaging is a type of flexible packaging. It is named after the shape it has: thin and long. Stick packaging is easy to handle, conveniently small, and suitable for on-the-go products. Industries such as food, pharmaceuticals, or manufacturers of single-dose products prefer using stick packs for their products. The stick packaging market in the Asia-Pacific region is projected to grow at th …
  • 発泡スチロール(EPS)市場(世界市場動向と予測)
    Expanded Polystyrene (EPS) is one of the most multipurpose polymers available for a variety of applications. EPS has found numerous application areas across a wide range of industries due to its light weight, rigidity, & thermal and acoustic insulating properties. EPS is majorly used in the building and construction industry. EPS in huge quantities are utilized to make insulation foam for closed c …
  • Contact Energy Limited:発電所及び企業SWTO分析2015
    Contact Energy Limited - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized …
  • フローラルフレーバーの世界市場2018-2022
    About Floral Flavors Floral flavors are flavoring ingredients and extracts that are obtained from natural flowers. Technavio’s analysts forecast the Global Floral Flavors Market 2018-2022 to grow at a CAGR of 9.95% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global Floral Flavors Market 2018-2022. To calculate the marke …
  • IPIN(インドアポジショニング及びインドアナビゲーション)の世界市場
    Technavios market research analyst estimates factors like the increased awareness and improved efficiency of indoor location services to spur market growth during the forecast period. The widespread implementation of IPIN solutions in business segments like healthcare, retail, aviation, and manufacturing is a significant factor that results in this markets remarkable CAGR of more than 42% by 2020. …
  • 原油流動性向上剤(COFI)の世界市場予測(~2021年):パラフィン抑制剤、アスファルテン抑制剤、スケール抑制剤、抗力減少剤、水化物抑制剤
    The global market size of COFI is estimated to reach USD 1.73 Billion by 2021 at a CAGR of 5.5%. Rise in worldwide crude oil production and increase in hydraulic fracturing, mainly from unconventional sources is driving the market. Different types of COFI are included in the report. The main types are paraffin inhibitors, scale inhibitors, hydrate inhibitors, asphaltene inhibitors, and drag-reduci …